Catalyst Wire Dossier Catalyst Wire Dossier

Tripegfilgrastim

Tripegfilgrastim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tripegfilgrastim, covering 2025-06-18 to 2025-06-18. Get the full timeline:

Most recent: Clinical Trial Update: Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers [Phase 2]

See pricing